Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2010

Jan 11, 2010

29745_dirs_2010-01-11_0114ac25-383a-4600-9a2e-768a49741f72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-01-01

Reporting Person: Tapiero Jacques (SVP&Pres.-Emerging Markets BU)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6212 Direct
Common Stock 10590 Indirect
Common Stock 1591 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee stock option 10/01 (right to buy) $79.28 2011-10-04 Common Stock (5000) Direct
Employee stock option 2/01 (right to buy) $73.98 2011-02-18 Common Stock (12000) Direct
Employee stock option 2/02 (right to buy) $75.92 2012-02-17 Common Stock (14000) Direct
Employee stock option 2/03 (right to buy) $57.85 2013-02-15 Common Stock (11000) Direct
Employee stock option 2/04 (right to buy) $73.11 2015-02-16 Common Stock (14000) Direct
Employee stock option 2/05 (right to buy) $55.65 2015-02-10 Common Stock (21302) Direct
Employee stock option 2/06 (right to buy) $56.18 2016-02-09 Common Stock (19578) Direct
Resticted Stock Unit $ 2012-10-01 Common Stock (12500) Direct
Restricted Stock Unit $ 2011-10-01 Common Stock (12500) Direct

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.